0001104659-23-023506.txt : 20230221
0001104659-23-023506.hdr.sgml : 20230221
20230221070122
ACCESSION NUMBER: 0001104659-23-023506
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230217
FILED AS OF DATE: 20230221
DATE AS OF CHANGE: 20230221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dahms Bradford D.
CENTRAL INDEX KEY: 0001787307
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40869
FILM NUMBER: 23645217
MAIL ADDRESS:
STREET 1: C/O SELECTA BIOSCIENCES, INC.
STREET 2: 480 ARSENAL WAY
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Theseus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001745020
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 830712806
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 314 MAIN STREET, SUITE 04-200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (857) 400-9491
MAIL ADDRESS:
STREET 1: 314 MAIN STREET, SUITE 04-200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
tm237110-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2023-02-17
0
0001745020
Theseus Pharmaceuticals, Inc.
THRX
0001787307
Dahms Bradford D.
C/O THESEUS PHARMACEUTICALS, INC.
314 MAIN STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
11.42
2023-02-17
4
A
0
105000
0.00
A
2033-02-17
Common Stock
105000
105000
D
The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 25% of the options vesting on February 17, 2024 and 1/48th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer.
/s/ Bradford Dahms
2023-02-21